References
- Manning P, Fazeli S, Lim V, et al. Invasive Lobular Carcinoma: A Multimodality Imaging Primer. Radiographics2022; 42 (4): 115–6.
- Anampa JD, Lin S, Obeng-Gyasi S, Xue X. Treatment and survival differences between patients with invasive lobular carcinoma versus invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev 2024; 34 (1): 125–32.
- Lim ST, Yu JH, Park HK, Moon BI, Ko BK, Suh YJ. A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population. World J Surg Oncol 2014.doi: 10.1186/1477-7819-12-56.
- Grabenstetter A, Mohanty AS, Rana S, et al.E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations. Hum Pat 2020;102: 44–53.
- Marinovich ML, Hunter KE, Macaskill P, Houssami N. Breast cancer screening using tomosynthesis or mammography: a meta-analysis of cancer detection and recall. J Natl Cancer Inst 2018; 110 (9): 942–9.
- Yasui H, Kawata T, Muramatsu K, et al. Expressions of N-terminal-deficient E-Cadherin protein in invasive lobular carcinoma of the breast. Am J Surg Pathology 2022; 46 (3): 383–91.
- Brem RF, Loffe M, Rapelyea JA, et al. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and Breast-Specific Gamma Imaging. Am J Roentgenol 2009; 192 (2): 379–83.
- Han B, Gu Z, Liu Z, Ling H. Clinical characteristics and survival outcomes of infiltrating lobular carcinoma: A retrospective study of 365 cases in China. Cancer Manag Res 2022; 14: 647–58.
- Jing Yu et al. Classical-type invasive lobular carcinoma with HER2 overexpression: clinical, histological, and hormone receptor characteristics. American J Clin Path 2011; 136 (1): 88–97.
- Yayoi Adachi Y, Ishiguro J, Kotani H, et al. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive carcinoma. BMC Cancer 2016; 16: 248.
- Ferro A, Eccher C, Caldara A. Invasive lobular (ILC) versus invasive ductal (IDC) breast cancer (BC): Clinical-pathological features and clinical outcomes in noninstitutional series. J Clin Oncol 2012; 30 (15): suppl. e21102.
- Luo Y, Ma A, Huang S, Yu Y. Invasive Lobular carcinoma has worse outcome compared with invasive ductal carcinoma in stage IC breast cancer with bone-only metastases. Breast care 2021; 17 (3): 296–305.
- Radhakrishan L, Mukherjee R, Singh BK, et al. Isolated ileocecal metastasis from lobular carcinoma a of the breast: A case report – Eur J Breast Health 2025. Doi: 10.4274
- Elangovan A, Hooda J, Savariau L, et al. Loss of E-cadherin induces IGF1R Activation and reveals a targetable pathway in invasive lobular breast carcinoma. Mol Cancer Res 2022; 20 (9): 1405–19.
- Mann RM, Hoogeveen YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res2008; 107(1): 1–14.
- Kombar OR, Fahmy DM, Brown MV, Farouk O, El-Damshety O. Sonomamographic characteristics of invasive lobular carcinoma. Breast Cancer 2012; 4: 115–24.
- Onega T, Abraham L, Miglioretti DL, et al. Digital mammography and digital breast tomosynthesis for detecting invasive lobular and ductal carcinoma. Breast Cancer Res Treat 2023; 202 (3): 505–14.
- Romanucci G, Zantedeschi L, Ventriglia A., et al. Lobular breast cancer conspicuity on digital breast tomosynthesis compared with synthesized 2D Mammography: a multi-reader study. J Imaging 2021; 7(9): 185.
- Mariscotti G, Durando M, Houssami N, et al. Digital breast tomosynthesis as adjunct to digital mammography for detecting and characterizing invasive lobular carcinoma. Clin Radiol 2016; 71 (9): 889–95.
- Clauser P, et al. Diagnostic performance of digital breast tomosynthesis versus digital mammography in a population clinically referred for breast imaging – a retrospective cohort study. Cancer Treat Res Com 2025. Doi.org/10.1016/j. ctarc.2025.100865
- European Commission Initiative on Breast Cancer (ECIBC). European guidelines for breast cancer screening and diagnosis: tomosynthesis recommendations 2023. < https://cancer-screening-and-care.jrc.ec.europa.eu/>
- <https://healthcare-quality.jrc.ec.europa.eu>
- Bernardi D, Belli P, Benelli E., et al. Digital breast tomosynthesis (DBT): Recommendations from the Italian college of breast radiologists by the Italian Society of Medical radiology and the Italian group for mammography screening. Breast Radiology 2017; 122: 723–30.
- Gao Y, Moy L, Heller SL. Digital breast tomosyn-thesis: update on technology, evidence and clinical practice. Radiographics 2021; 41(2): 321–37.
- Shia WC, Kuo YH, Hsu FR, et al. Evaluating the margins of breast cancer tumors by using digital breast tomosynthesis with deep learning: a preliminary assessment. Diagnostics (Basel) 2024; 14(10): 1032.
- Wang R, Chen f, Chen H, et al. Deep learning in digital breast tomosynthesis: current status, challenges, and future trends. MedComm 2025; 6(6); e70247.
- Ko MJ, Park DA, Kim SH, et al. Accuracy of digital breast tomosynthesis for detecting breast cancer in the diagnostic setting: a systematic review and meta-analysis. Korean J Radiol 2021; 22(8): 1240–52.